Transrectal prostate colour Doppler ultrasound (TRUS) is a medical imaging technique used to evaluate the prostate gland for abnormalities or disease. It is a non-invasive procedure that uses sound waves to create images of the prostate and surrounding tissues. The procedure is performed using a small ultrasound probe that is inserted into the rectum, allowing for a clear view of the prostate gland.
Why is a Transrectal prostate colour Doppler ultrasound (TRUS)performed?
TRUS is often used to evaluate the prostate gland for signs of cancer, as well as other conditions such as prostate enlargement, inflammation, or infection. It may also be used to guide a biopsy of the prostate gland, allowing for the collection of tissue samples for further analysis.
The procedure is typically recommended for men who have an elevated prostate-specific antigen (PSA) level, abnormal results on a digital rectal exam, or other symptoms such as difficulty urinating or frequent urination.
What happens during a TRUS?
Before the procedure, the patient will be asked to empty their bladder and may be given an enema to clean out the rectum. The patient will then lie on their side with their knees bent and pulled up to their chest.
The ultrasound probe is then lubricated and inserted into the rectum, allowing for a clear view of the prostate gland. The technician will move the probe around to obtain images from different angles, using the colour Doppler function to evaluate blood flow within the prostate gland.
During the procedure, the patient may feel some discomfort or pressure, but it is generally not painful. The procedure typically takes 10 to 20 minutes to complete.
What are the risks and limitations of TRUS?
Like any medical procedure, there are some risks associated with TRUS. These include bleeding, infection, and discomfort during the procedure. However, these risks are rare and can be minimized by following proper medical protocols.
TRUS is generally considered a safe and effective imaging technique for evaluating the prostate gland. However, it does have some limitations. For example, TRUS may not be able to detect small or early-stage tumors, and it may not be able to distinguish between benign and malignant growths. Additionally, TRUS may not be effective for evaluating the prostate gland in men with certain medical conditions or anatomical abnormalities.
Conclusion
Transrectal prostate colour Doppler ultrasound (TRUS) is a non-invasive imaging technique used to evaluate the prostate gland for abnormalities or disease. It is typically used to evaluate the prostate gland for signs of cancer, as well as other conditions such as prostate enlargement, inflammation, or infection. The procedure is generally safe and effective, although it does have some limitations. If you are considering a TRUS, talk to your healthcare provider to determine if it is right for you.